Doximity, Inc. Class A Common Stock (DOCS)
25.59
+0.85 (3.44%)
NYSE· Last Trade: Aug 27th, 7:07 PM EDT
Detailed Quote
| Previous Close | 24.74 |
|---|---|
| Open | 25.13 |
| Bid | 25.42 |
| Ask | 25.72 |
| Day's Range | 24.89 - 25.81 |
| 52 Week Range | 17.15 - 76.51 |
| Volume | 2,467,610 |
| Market Cap | 4.74B |
| PE Ratio (TTM) | 21.32 |
| EPS (TTM) | 1.2 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 7,350,042 |
Chart
About Doximity, Inc. Class A Common Stock (DOCS)
Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More
News & Press Releases
What Happened? A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intellige...
Via StockStory · August 27, 2026
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings gro...
Via StockStory · August 27, 2026
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't.
By Doximity · Via Business Wire · August 25, 2026
This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.
Via The Motley Fool · August 18, 2026
Doximity (NYSE:DOCS) Surges on AI Engagement Momentum Despite EPS Miss and Soft Guidancechartmill.com
Via Chartmill · August 6, 2026
Sitaram's sale was driven by tax obligations from option exercises and RSU vesting, not a shift in conviction.
Via The Motley Fool · August 18, 2026
Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.
Via The Motley Fool · August 18, 2026
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Via The Motley Fool · August 18, 2026
Tangney executed a non-discretionary sale to cover tax withholding on vesting equity awards.
Via The Motley Fool · August 18, 2026
Revenue grew 7% as AI adoption accelerated, with AI Scribe users surging 10-fold in July.
Via The Motley Fool · August 13, 2026
What Happened? A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was comple...
Via StockStory · August 13, 2026
Doximity’s second quarter results were met with a notably positive market reaction following revenue that surpassed Wall Street expectations and ongoing mome...
Via StockStory · August 13, 2026
GitLab, UiPath, and Asana have similar setups that could lead to big post-earnings jumps.
Via The Motley Fool · August 11, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · August 10, 2026
The leading digital platform for U.S. medical professionals is becoming a formidable force in the AI race.
Via The Motley Fool · August 8, 2026
Doximity (NYSE:DOCS) reported fiscal 2027 first-quarter revenue of $157 million, up 7% from a year earlier, as the company cited improving demand from pharmaceutical and hospital customers and increased engagement with its clinical artificial intelligence tools.
Adjusted EBITDA totaled $75 million,
Via MarketBeat · August 8, 2026
Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 7.3% year on year to $156....
Via StockStory · August 7, 2026
Which stocks are gapping on Friday?chartmill.com
Via Chartmill · August 7, 2026
Top movers in Friday's pre-market sessionchartmill.com
Via Chartmill · August 7, 2026
Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out
Via Benzinga · August 7, 2026
Medical professional network Doximity (NYSE:DOCS) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 7.3% year on year to ...
Via StockStory · August 6, 2026
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came out
Via Benzinga · August 6, 2026
Curious about the stocks that are showing activity after the closing bell on Thursday?chartmill.com
Via Chartmill · August 6, 2026
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026.
By Doximity · Via Business Wire · August 6, 2026
Medical professional network Doximity (NYSE:DOCS) will be announcing earnings results this Thursday afternoon. Here’s what investors should know. Doximity me...
Via StockStory · August 4, 2026